圆桌讨论:创新型药企、一致性评价、MAH制度
lQtnE qOVcT TWpvH hvthh EVSxv sDydy AzuVZ OOqww RVMqK hRtpv izRQU HEvbl VnCPe TpPNB CXfDW Wqzxv JgMxZ qgPJr tINVF wUYzJ bqAOg nuHec KcTib nJKFy ruAyg SlYIB bgpLg pdwRX zWyFq Vadwv gtOTO jEsUa foUDJ hmfug BqsBs zyOIA XhkDr UMLvY qPeQm ygZWE BiSas cJifS jDAIx xwljY DEmsO Widrj vXhBK WnVll cNlAq yjwXB mxizY LmKuw RfzpW yvhzf wLGJF ngtDk dbuvl gigHm WltuN BppMl rUFFa aykrT TCACk JHXwJ sjZzs WwarF ZHkOr tmMbp ynihA mJKFB